Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (31-40 of 373) with videos related to

Pageof 38
Sort By:
Current Medical Research and Opinion|December 18, 2009
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?Iain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2001
Individualizing target haemoglobin concentrations--tailoring treatment for renal anaemiaI C Macdougall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2011
New anemia therapies: translating novel strategies from bench to bedsideIain C Macdougall
Current Opinion in Hematology|May 5, 1999
Optimizing erythropoietin therapyI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2005
Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risksIain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2004
Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?Iain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?Iain C Macdougall
The Hastings Center Report|October 8, 1998
Adam and the implantJ C MacDougall
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2007
Novel erythropoiesis-stimulating agents: a new era in anemia managementIain C Macdougall
Pageof 38

Showing results (31-40 of 373) with videos related to

Sort By:
Pageof 38
Current Medical Research and Opinion|December 18, 2009
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?Iain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2001
Individualizing target haemoglobin concentrations--tailoring treatment for renal anaemiaI C Macdougall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2011
New anemia therapies: translating novel strategies from bench to bedsideIain C Macdougall
Current Opinion in Hematology|May 5, 1999
Optimizing erythropoietin therapyI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2005
Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risksIain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2004
Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?Iain C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?Iain C Macdougall
The Hastings Center Report|October 8, 1998
Adam and the implantJ C MacDougall
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2007
Novel erythropoiesis-stimulating agents: a new era in anemia managementIain C Macdougall
Pageof 38